International Standards for Tuberculosis Care: Revisiting the cornerstones of tuberculosis care and control

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 1, 2007, Pages 61-65

  Fair, Elizabeth ^a   Hopewell, Philip C ^a   Pai, Madhukar ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Guidelines; Recommendations; Standards; Tuberculosis

Indexed keywords

AMIKACIN; ANTIRETROVIRUS AGENT; CAPREOMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFATER; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG CHOICE; DRUG EFFICACY; EPIDEMIC; EVIDENCE BASED MEDICINE; EXTRAPULMONARY TUBERCULOSIS; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTERNATIONAL COOPERATION; LUNG TUBERCULOSIS; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT CARE; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; SEROLOGY; SOCIAL SUPPORT; SPUTUM ANALYSIS; STANDARDIZATION; THERAPEUTIC ERROR; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; UNSPECIFIED SIDE EFFECT; HEALTH; REVIEW; STANDARD; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HUMANS; INTERNATIONALITY; REFERENCE STANDARDS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 33947713376     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.1.61     Document Type: Article

References (22)

1. WHO, Global Tuberculosis Control. Surveillance, planning, financing. WHO Report. WHO, Geneva, 1-247 (2005).
2. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9), 1009-1021 (2003).
3. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7), 677-686 (1999).
4. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293(22), 2767-2775 (2005).
5. Uplekar M. Involving private health care providers in delivery of TB care: global strategy. Tuberculosis (Edinb.) 83(1-3), 156-164 (2003).
6. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet 358(9285), 912-916 (2001).
7. WHO. Involving private practitioners in tuberculosis control: issues, interventions, and emerging policy framework. WHO, Geneva, Switzerland 1-81 (2001).
8. WHO. Public-private mix for DOTS. Practical tools to help implementation. WHO, Geneva, Switzerland (2003).
9. Lonnroth K, Thuong LM, Linh PD, Diwan VK. Delay and discontinuity - a survey of TB patients' search of a diagnosis in a diversified health care system. Int. J. Tuberc. Lung Dis. 3(11), 992-1000 (1999).
10. Olle-Goig JE, Cullity JE, Vargas R. A survey of prescribing patterns for tuberculosis treatment amongst doctors in a Bolivian city. Int. J. Tuberc. Lung Dis. 3(1), 74-78 (1999).
11. Prasad R, Nautiyal RG, Mukherji PK, Jain A, Singh K, Ahuja RC.. Diagnostic evaluation of pulmonary tuberculosis: what do doctors of modern medicine do in India? Int. J. Tuberc. Lung Dis. 7(1), 52-57 (2003).
12. Shah SK, Sadiq H, Khalil M et al. Do private doctors follow national guidelines for managing pulmonary tuberculosis in Pakistan? East Mediterr. Health J. 9(4), 776-788 (2003).
13. Singla N, Sharma PP, Singla R, Jain RC. Survey of knowledge, attitudes and practices for tuberculosis among general practitioners in Delhi, India. Int. J. Tuberc. Lung Dis.. 2(5), 384-389 (1998).
14. Suleiman BA, Houssein AI, Mehta F, Hinderaker SG. Do doctors in north-western Somalia follow the national guidelines for tuberculosis management? East Mediterr. Health J. 9(4), 789-795 (2003).
15. Uplekar MW Shepard DS. Treatment of tuberculosis by private general practitioners in India. Tubercle 72(4), 284-290 (1991).
16. International Standards for Tuberculosis Care (ISTC). Tuberculosis Coalition for Technical Assistance, The Hague, Holland (2006).
17. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect. Dis. 6(11), 710-725 (2006).
18. Raviglione M. XDR-TB: entering the post-antibiotic era? Int. J. Tuberc. Lung Dis.. 10(11), 1185-1187 (2006).
19. The tuberculosis X factor. Lancet Infect. Dis. 6(11), 679 (2006).
20. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N. Engl. J. Med. 333(4), 229-233 (1995).
21. Bloch AB, Cauthen GM, Onorato IM et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271(9), 665-671 (1994).
22. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 72(2), 213-220 (1994).